Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615001044516
ACTRN12615001044516
Not yet recruiting
Phase 4

A pilot study of the effects of Methylphenidate (MPD) on cognition, mood, behaviour, participation and quality of life after severe traumatic brain injury in adults

Royal Rehab0 sites20 target enrollmentOctober 7, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTraumatic brain injuryPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationInjuries and Accidents - Other injuries and accidents

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Traumatic brain injury
Sponsor
Royal Rehab
Enrollment
20
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 7, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •A participant is identified to be eligible if they are aged between 18\-65yo, have a new traumatic brain injury within the past 6 months, a measurable PTA of greater than 7 days.
  • •All participants need to be able to give informed consent.

Exclusion Criteria

  • •Non\-English speaking
  • •Current treatment with psycho\-active medications
  • •cardiac events
  • •hypertension
  • •abnormal ECG
  • •post\-traumatic seizures
  • •pregnancy (negative bhCG)
  • •prior history of alcohol or drug abuse
  • •Any medications which are contra\-indicated with MPD: monoamine oxidase inhibitors, clonidine, dopamine agonists or antagonists, certain anaesthetics

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
????? ????? ???? ??????(???????) ?? ??? ??? ??????? ??????? ?? ???? ???? ????????
IRCT20240415061495N1Oroumia University of Medical Sciences962
Completed
Phase 2
Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan City
IRCT2015092624209N1Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40
Completed
Phase 3
Investigating the effectiveness of methylphenidate and multi chain polyunsaturated fatty acids in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan CityAttention deficit hyperactivity disorder (ADHD).Disturbance of activity and attention
IRCT2015092724209N2Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40
Recruiting
Phase 3
Investigating the effect of methylphenidate on the level of consciousness in loss of consciousness patients due to poisoning
IRCT20220305054196N4Shahid Beheshti University of Medical Sciences64
Recruiting
Phase 4
Effect of Methylphenidate on understanding intentionality in ADHD childre
IRCT20201103049254N1Tehran University of Medical Sciences20